- Home
- BJRI vs ABCL Comparison
BJRI vs ABCL Comparison
Compare BJRI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJRI
- ABCL
- Stock Information
- Founded
- BJRI 1978
- ABCL 2012
- Country
- BJRI United States
- ABCL Canada
- Employees
- BJRI N/A
- ABCL N/A
- Industry
- BJRI Restaurants
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- BJRI Consumer Discretionary
- ABCL Health Care
- Exchange
- BJRI Nasdaq
- ABCL Nasdaq
- Market Cap
- BJRI 756.7M
- ABCL 719.0M
- IPO Year
- BJRI 1996
- ABCL 2020
- Fundamental
- Price
- BJRI $35.34
- ABCL $2.76
- Analyst Decision
- BJRI Hold
- ABCL Buy
- Analyst Count
- BJRI 7
- ABCL 3
- Target Price
- BJRI $37.50
- ABCL $8.50
- AVG Volume (30 Days)
- BJRI 336.1K
- ABCL 2.5M
- Earning Date
- BJRI 10-31-2024
- ABCL 11-04-2024
- Dividend Yield
- BJRI N/A
- ABCL N/A
- EPS Growth
- BJRI 95.73
- ABCL N/A
- EPS
- BJRI 1.26
- ABCL N/A
- Revenue
- BJRI $1,336,598,000.00
- ABCL $32,962,000.00
- Revenue This Year
- BJRI $3.13
- ABCL N/A
- Revenue Next Year
- BJRI $3.35
- ABCL $38.78
- P/E Ratio
- BJRI $28.02
- ABCL N/A
- Revenue Growth
- BJRI N/A
- ABCL N/A
- 52 Week Low
- BJRI $27.61
- ABCL $2.34
- 52 Week High
- BJRI $38.87
- ABCL $6.06
- Technical
- Relative Strength Index (RSI)
- BJRI 51.60
- ABCL 50.74
- Support Level
- BJRI $33.63
- ABCL $2.61
- Resistance Level
- BJRI $37.51
- ABCL $3.18
- Average True Range (ATR)
- BJRI 1.18
- ABCL 0.19
- MACD
- BJRI -0.22
- ABCL -0.02
- Stochastic Oscillator
- BJRI 50.00
- ABCL 38.24
About BJRI BJ's Restaurants Inc.
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in one operating segment that is casual dining company-owned restaurants. It has geographic presence only in the United States of America.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.